Home » Eric Yang

Eric Yang

Associate Principal

Eric Yang was an Associate Principal at CBPartners.

Connect with Eric Yang

-

-

LinkedIn

Published Articles

Digital Therapeutics as Digital Companions: Models for Effective Pharma Partnerships

Pharma and biotech companies should be prepared to make long-term investments in capability building, market development, and evidence generation to maximize the value of digital companions.

Access and Reimbursement: Access to Digital Therapeutics in a Post-COVID-19 World

CBPartners’ in collaboration with Eric Bernath, explores the current USA access landscape, processes and pitfalls for companion digital therapeutics (DTx), as well as how the space is likely to evolve in the future, and lays out some best practices as suggested by USA payers to maximize chances of reimbursement.

ISPOR Annual 2020: OCM to OCF: Implications for Total Cost of Care

A research poster that aims to map the limitations of the OCM to the proposed features of the 2021 OCF model in order to evaluate whether the OCF is more likely to successfully reduce total cost of care.

ISPOR Annual 2020: Evaluating the HTA Impact of Real-World Evidence from Formal Orphan Drug Registries

This research poster aims to perform a comparative assessment of the formal registry requirements in Germany and Brazil for orphan therapies with limited clinical evidence in order to pinpoint the future role of real-world evidence (RWE) in health technology assessments (HTAs).